Erythromycin Ethyl Succinate

Erythromycin Ethyl Succinate

✔ Pharmacopoeial Grade: Complies with IP (Indian Pharmacopoeia) standards ensuring high purity and consistent quality.
✔ Prodrug Form: Converts to active Erythromycin in the body, enhancing bioavailability and reducing gastric irritation.
✔ Broad-Spectrum Efficacy: Effective against a wide range of Gram-positive and Gram-negative bacteria.
✔ Applications: Suitable for use in oral suspensions, tablets, and capsule formulations.
✔ Excellent Stability: Improved chemical stability and shelf life compared to other Erythromycin derivatives.
✔ Therapeutic Uses: Commonly used to treat respiratory tract, skin, and soft tissue infections.
✔ Manufacturing Quality: Produced under strict GMP conditions ensuring global standard compliance and safety.

Category:

Description

Erythromycin Ethyl Succinate (API IP Grade) is a premium-quality macrolide antibiotic active pharmaceutical ingredient (API) designed to meet Indian Pharmacopoeia standards. It is a prodrug of Erythromycin that becomes active upon hydrolysis in the body, offering enhanced stability and improved gastrointestinal tolerance. Widely used in the formulation of oral suspensions, tablets, and capsules, this API is effective against a broad spectrum of bacterial infections, including respiratory, skin, and soft tissue infections. Its high purity, consistent particle size, and superior solubility make it ideal for pharmaceutical manufacturing and global export.

Reviews

There are no reviews yet.

Be the first to review “Erythromycin Ethyl Succinate”

Your email address will not be published. Required fields are marked *